|
|
 |
|
|
|
 |
Science |
|
- Krousel-Wood M, Andersson HC, Rice J, Jackson KE , Rosner E, Lubin
IM. Physicians Perceived Usefulness of and Satisfaction with Test
Reports for Cystic Fibrosis (DF508) and Factor V Leiden. Gen In Med,
vol5(3):166-171, 2003
- Andersson HC, MA Krousel-Wood, KE Jackson, J Rice, IM Lubin. Medical
Genetic Test Reporting in Molecular Cystic Fibrosis and Factor V Leiden
Tests Based On Reports Solicited From North American Laboratories. Gen
in Med 4(5):324-7 2002. -
Abstract
- General
Recommendations for Quality Assurance Programs for Laboratory Molecular
Genetic Tests
|
| |
People |
|
Coming soon! |
|
|
|
|
|
Policy |
|
- Dequeker E. Cuppens H. Dodge J. Estivill X. Goossens M. Pignatti
PF. Scheffer H. Schwartz M. Schwarz M. Tummler B. Cassiman JJ.
Recommendations for quality improvement in genetic testing for
cystic fibrosis. European Concerted Action on Cystic Fibrosis.
European Journal of Human Genetics. 8 Suppl 2:S2-24, 2000.
- Schwartz MK. Genetic testing and the clinical
laboratory improvement amendments of 1988: present and future.
[Journal Article] Clinical Chemistry. 45(5):739-45, 1999 May.
- McGovern MM. Benach MO. Wallenstein S. Desnick RJ. Keenlyside R.
Quality assurance in molecular genetic testing laboratories. JAMA.
281(9): 835-40, 1999.
- Hofgartner WT. Tait JF. Frequency of problems during clinical
molecular-genetic testing. American Journal of Clinical Pathology.
112(1):14-21, 1999.
- Schwind EL. Wolfe M. Greendale K. Misra LM. Pass KA. Wallerstein
R. Cystic fibrosis carrier screening practices in an ethnically
diverse region: experience of the Genetic Network of the Empire
State, Puerto Rico, and the U.S. Virgin Islands. Genetic Testing.
3(2):215-8, 1999
- Giardiello FM, Brensinger JD, Peterson GM, Luce MC, Hylind LM,
Bacon JA, Booker SV, Parker RD, and Hamilton SR. The use and
interpretation of commercial APC gene testing for familial
adenomatous polyposis. New England Journal of Medicine, 336 (12)
823-827, 1997.
|
This page last reviewed: 8/19/2004
|
|